Treatment of Irritable Bowel Syndrome Using Complementary and Alternative Medicine

被引:39
作者
Chang, Full-Young [1 ]
Lu, Ching-Liang
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei 112, Taiwan
关键词
acupuncture; complementary and alternative medicine; functional gastrointestinal disorder; herbal medicine; irritable bowel syndrome; FUNCTIONAL GASTROINTESTINAL DISORDERS; PLACEBO-CONTROLLED TRIAL; CHINESE HERBAL MEDICINE; DOUBLE-BLIND; PEPPERMINT-OIL; DIOCTAHEDRAL SMECTITE; CLINICAL-TRIAL; HEALTH-CARE; ALOE-VERA; DIARRHEA;
D O I
10.1016/S1726-4901(09)70375-2
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The therapeutic objectives for irritable bowel syndrome (IBS) patients are to improve their functioning in society. Accordingly, recommended management is to develop a logical strategy including a positive diagnosis, consideration of the patient's agenda and emotional state, critical appraisal of the efficacies of various drugs and a graded therapeutic response. Unfortunately, none of the currently available drugs (e.g. antispasmodics, antidiarrheals, osmotics, cathartics, bulking agents, tranquilizers, sedatives) are globally effective in treating all IBS symptoms, and the advanced receptor-targeted drugs are not always successfully and safely marketed. Consequently, more than half of patients may seek complementary and alternative medicine (CAM) to treat the annoying bowel symptoms. Physicians have considered these CAM measures to have an "enhanced placebo effect". For example, many herbal medicine and plant products are globally used to treat IBS, whereas their efficacies are often inconclusive because of small sample sizes, inadequate data analyses and lack of standardized preparations. Meta-analyses do not establish their true efficacy. Acupuncture has long been employed by patients themselves to treat functional gastrointestinal disorders with satisfactory response, but its effect on IBS does not seem to be promising. Peppermint oil, melatonin and clay-like materials are effective in treating some IBS symptoms, while their true pharmacology remains enigmatic. In conclusion, IBS treatment is usually tailored to the individual's manifestations, ranging from reassurance to psychotherapy. Apart from conventional medications, CAM may be considered individually as a supplement or alternative to treat IBS patients that is at least equal in effect to placebo if patients do not exhibit any intolerable or serious side effects. [J Chin Med Assoc 2009;72(6):294-300]
引用
收藏
页码:294 / 300
页数:7
相关论文
共 72 条
[1]
Treatment of irritable bowel syndrome with Chinese herbal medicine - A randomized controlled trial [J].
Bensoussan, A ;
Talley, NJ ;
Hing, M ;
Menzies, R ;
Guo, A ;
Ngu, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1585-1589
[2]
BENSOUSSAN A, 2001, J CHIN MED ASSOC, V64, P487
[3]
Novel therapeutic approaches in IBS [J].
Bradesi, Sylvie ;
Mayer, Emeran A. .
CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (06) :598-604
[5]
INFLUENCE OF SEROTONIN AND MELATONIN ON SOME PARAMETERS OF GASTROINTESTINAL ACTIVITY [J].
BUBENIK, GA ;
DHANVANTARI, S .
JOURNAL OF PINEAL RESEARCH, 1989, 7 (04) :333-344
[6]
Peppermint oil (Mintoil®) in the treatment of irritable bowel syndrome:: A prospective double blind placebo-controlled randomized trial [J].
Cappello, G. ;
Spezzaferro, M. ;
Grossi, L. ;
Manzoli, L. ;
Marzio, L. .
DIGESTIVE AND LIVER DISEASE, 2007, 39 (06) :530-536
[7]
Chan J, 1997, HEPATO-GASTROENTEROL, V44, P1328
[8]
Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome [J].
Chang, Full-Young ;
Lu, Ching-Liang ;
Chen, Chih-Yen ;
Luo, Jiing-Chyuan .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (12) :2266-2272
[9]
Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance (vol 336, pg 556, 2008) [J].
不详 .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[10]
Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome [J].
Davis, K. ;
Philpott, S. ;
Kumar, D. ;
Mendall, M. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (09) :1080-1086